MAb L9E10 to blood group H2 antigen binds to colon cancer stem cells and inhibits tumor cell migration and invasion

Hybridoma

Volumn 29, Issue 4, 2010, Pages 355-359

  Xu, Mai ^a   Wang, Fan ^b   Gildersleeve, Jeffrey C ^c   Achilefu, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PEKING UNIVERSITY   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP H ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY L9E10; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER STEM CELL; CELL MIGRATION; COLON CANCER; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; TUMOR CELL;

ABO BLOOD-GROUP SYSTEM; AGGLUTINATION TESTS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARBOHYDRATES; CELL MOVEMENT; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYBRIDOMAS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; TUMOR CELLS, CULTURED;

HELICOBACTER PYLORI;

EID: 77955862081     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2010.0020     Document Type: Article

References (32)

1. Hakomori S: Antigen structure and genetic basis of histoblood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1999;1473:247-266.
2. Cao Y, Merling A, Karsten U, and Schwartz-Albiez R: The fucosylated histo-blood group antigens H type 2 (blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes. Glycobiology 2001;11:677-683.
3. Fujitani N, Liu Y, Toda S, Shirouzu K, Okamura T, and Kimura H: Expression of H type 1 antigen of ABO histoblood group in normal colon and aberrant expressions of H type 2 and H type 3/4 antigens in colon cancer. Glycoconj J 2000;17:331-338.
4. Brown A, Ellis IO, Embleton MJ, Baldwin RW, Turner DR, and Hardcastle JD: Immunohistochemical localization of Y hapten and the structurally related H type-2 blood-group antigen on large-bowel tumours and normal adult tissues. Int J Cancer 1984;33:727-736.
5. Dabelsteen E, Graem N, Clausen H, and Hakomori S: Structural variations of blood group A antigens in human normal colon and carcinomas. Cancer Res 1988;48:181-187.
6. Yazawa S, Akamatsu S, Tachikawa T, Naito H, Nakamura J, Asao T, Nagamachi Y, Nakajima T, Shin S, and Chia D: Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer. Jpn J Cancer Res 1993;84:641-648.
7. Bryne M, Thrane PS, and Dabelsteen E: Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinomas. Cancer 1991; 67:613-618.
8. Greenwell P: Blood group antigens: molecules seeking a function? Glycoconj J 1997;14:159-173.
9. Prokopishyn NL, Puzon-McLaughlin W, Takada Y, and Laferte S: Integrin alpha3beta1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes. J Cell Biochem 1999;72:189-209.
10. Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, Campbell PL, Volin MV, Backer AE, and Koch AE: Ley/H: an endothelial-selective, cytokineinducible, angiogenic mediator. J Immunol 2000;164:4868-4877.
11. Karsten U, Papsdorf G, Pauly A, Vojtesek B, Moll R, Lane EB, Clausen H, Stosiek P, and Kasper M: Subtypes of nontransformed human mammary epithelial cells cultured in vitro: histo-blood group antigen H type 2 defines basal cellderived cells. Differentiation 1993;54:55-66.
12. O'Brien CA, Pollett A, Gallinger S, and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-110.
13. Ricci-Vitiani L, Lombardi DG, Pilozzi E, BiffoniM, Todaro M, Peschle C, and De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-115.
14. Kohler G, and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256:495-497.
15. Oyelaran O, McShane LM, Dodd L, and Gildersleeve JC: Profiling human serum antibodies with a carbohydrate antigen microarray. J Proteome Res 2009;8:4301-4310.
16. Oyelaran O, and Gildersleeve JC: Application of carbohydrate array technology to antigen discovery and vaccine development. Expert Rev Vaccines 2007;6:957-969.
17. Robbe-Masselot C, Herrmann A, Maes E, Carlstedt I, Michalski JC, and Capon C: Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon. J Proteome Res 2009;8:702-711.
18. Therkildsen MH, Mandel U, Christensen M, Barfoed C, and Dabelsteen E: Altered expression of ABO (H) carbohydrate antigens is seen in pleomorphic adenomas. Apmis 1992;100: 415-423.
19. Limas C, Lange P, Fraley EE, and Vessella RL: A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course. Cancer 1979;44:2099-2107.
20. Ilantzis C, Jothy S, Alpert LC, Draber P, and Stanners CP: Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis. Lab Invest 1997;76:703-716.
21. Ichikawa D, Handa K, and Hakomori S: Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int J Cancer 1998;76:284-289.
22. Inoue M, Sasagawa T, Saito J, Shimizu H, Ueda G, Tanizawa O, and Nakayama M: Expression of blood group antigens A, B, H, Lewis-a, and Lewis-b in fetal, normal, and malignant tissues of the uterine endometrium. Cancer 1987;60:2985-2993.
23. Cooper HS, Malecha MJ, Bass C, Fagel PL, and Steplewski Z: Expression of blood group antigens H-2, Le(y), and sialylated-Le(a) in human colorectal carcinoma. An immunohistochemical study using double-labeling techniques. Am J Pathol 1991;138:103-110.
24. Molne J, Bjorquist P, Andersson K, Diswall M, Jeppsson A, Strokan V, Rydberg L, and Breimer ME: Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte-and cardiomyocyte-like cells. Transplantation 2008;86:1407-1413.
25. Miyake M, and Hakomori SI: A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry 1991;30:3328-3334.
26. Kimmel KA, Carey TE, Judd WJ, and McClatchey KD: Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant. J Natl Cancer Inst 1986; 76:9-19.
27. Nakajima T, Yazawa S, Miyazaki S, and Furukawa K: Immunochemical characterization of anti-H monoclonal antibodies obtained from a mouse immunized with human saliva. J Immunol Methods 1993;159:261-267.
28. Iyer YS, Vasantha K, Pujari V, Jadhav S, and Ghosh K: Murine monoclonal anti-H as typing reagent. Indian J Med Res 2009;129:72-74.
29. Sugita K, Nakazawa S, Mori T, Nishino K, Abe T, Kinoshita A, Suzuki T, Saito M, Kikuchi H, Osano M, et al: [Monoclonal antibodies against human erythrocyte membrane antigens and the antigens recognized by these antibodies]. Nippon Ketsueki Gakkai Zasshi 1989;52:561-568.
30. Li H, Pan JC, Liu Z, Liu JH, and Zhang JG: [Preparation and characterization of non-agglutinating mAbs against membrane antigen on human erythrocytes]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2005;21:473-475.
31. Boren T, Falk P, Roth KA, Larson G, and Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892-1895.
32. Alkout AM, Blackwell CC, Weir DM, Poxton IR, Elton RA, Luman W, and Palmer K: Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis(a), and Lewis(b) antigens. Gastroenterology 1997;112:1179-1187.